Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,348
NCT01745887
A Multi-Center Study Subjects With Dry Eye Syndrome
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2012
Completion: Nov 30, 2012
NCT01748578
Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects
Completion: Mar 31, 2013
NCT01998802
Phase 3 Study of EBI-005 in Dry Eye Disease
Phase: Phase 3
Start: Jan 31, 2014
Completion: Apr 30, 2015
NCT02082899
A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)
Phase: Phase 2
Start: Feb 28, 2014
Completion: Jul 31, 2014
NCT02405039
Study of EBI-005 in Dry Eye Disease (DED)
Start: Apr 30, 2015
Completion: Jul 31, 2016
NCT02492321
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
Start: Jul 31, 2015
Completion: Dec 31, 2015
NCT02842541
Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema
Start: Sep 30, 2016
Completion: Feb 28, 2018